Coagulation Analyzers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Coagulation Analyzers Market is segmented by Product (Analyzers, Consumables), Test Type, Technology, End-User and Geography

Market Snapshot

Coagulation Testing Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.85 %
Coagulation Analyzers Market Companies

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Coagulation Analyzers are used for detecting the presence of blood clots in the blood vessels. These analyzers measure coagulation pathway speed as well as thrombolin & thromboplastin levels in a few minutes. A coagulation analyzer system also has built-in quality control and security lockout protocols to ensure safe and secure use, as it is used on sensitive information about patient's health.

The global coagulant analyzer market is driven by rise in the geriatric population, an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases, development of point of care (POC) coagulation testing, and the surge in laboratory automation. However, the high cost of fully automated coagulation analyzer and slow adoption of advanced hemostasis instruments in developing and underdeveloped economies are restraining the market growth.

Scope of the Report

As per the scope of the report, a coagulation analyzer or a micro-coagulation system is a device that measures and evaluates the speed of clot formation or blood coagulation.

By Product
Clinical Laboratory Analyzers
Point of Care Analyzers
By Test Type
Fibrinogen Testing
D-Dimer Testing
Platelet Function Tests
Other Coagulation Tests
By Technology
Optical Technology
Mechanical Technology
Electrochemical Technology
By End User
Diagnostic Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

D-Dimer Testing is Expected to Dominate the Market During the Forecast Period

D-dimer is one of the protein fragments produced when a blood clot gets dissolved in the body. It is usually undetectable or detectable at a very low amount unless the body is forming and breaking down blood clots. Then, its level in the blood can significantly rise. This test detects D-dimer in the blood.

It has been observed by the studies that an increased D-dimer and t-PA antigen levels are associated with Coronary Heart Disease (CHD) risk. As deaths due to Cardiovascular disease is expected to increase, the need for instruments used for analyzing D-Dimer is expected to increase, as this will help to understand CHD better. For instance, the World Health Organization has stated that cardiovascular diseases are the number one cause of deaths across the globe taking an estimated 17.9 million lives each year. Therefore, rising mortality associated with cardiovascular diseases is believed to augment the demand for D-Dimer testing.

Blood Coagulants Market Trends

North America is Expected to Dominate the Coagulation Analyzers Market

North America holds the largest share of the coagulation analyzers market which is majorly attributed to the well-established healthcare system acorss the countries such as United States and Canada and the large market of medical devices which is due to the presence of all international companies.

Asia-Pacific region is expected to witness rapid growth in the future which is due to the increasing adoption of technology and focus of the healthcare companies to enter the emerging economies such as India. 

Coagulation Analyzers Market Share

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. The competition is fierce due to the consolidated nature of the market with top companies reporting to occupy major share in the market. The key players in the market are adopting various strategic moves to sustain the intense competition.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Chronic Blood Disorders

      2. 4.2.2 Rising Geriatric Population Coupled with Increasing Prevalence of Chronic Diseases

      3. 4.2.3 Increasing Laboratory Automation

    3. 4.3 Market Restraints

      1. 4.3.1 Slow Adoption Rate in Underdeveloped Economies

      2. 4.3.2 High Cost of Test for Fully Automated Analyzers

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Analyzers

        1. Clinical Laboratory Analyzers

        2. Point of Care Analyzers

      2. 5.1.2 Consumables

    2. 5.2 By Test Type

      1. 5.2.1 Fibrinogen Testing

      2. 5.2.2 D-Dimer Testing

      3. 5.2.3 Platelet Function Tests

      4. 5.2.4 Other Coagulation Tests

    3. 5.3 By Technology

      1. 5.3.1 Optical Technology

      2. 5.3.2 Mechanical Technology

      3. 5.3.3 Electrochemical Technology

      4. 5.3.4 Others

    4. 5.4 By End User

      1. 5.4.1 Hospitals

      2. 5.4.2 Diagnostic Centers

      3. 5.4.3 Others

    5. 5.5 Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America

    6. 5.6

    7. 5.7


    1. 6.1 Company Profiles

      1. 6.1.1 Nihon Kohden Corporation

      2. 6.1.2 F. Hoffmann-La Roche Ltd

      3. 6.1.3 Siemens Healthcare

      4. 6.1.4 DMS Imaging

      5. 6.1.5 Sysmex Corporation

      6. 6.1.6 Thermo Fisher Scientific Inc

      7. 6.1.7 Diagnostica Stago Sas

      8. 6.1.8 Helena Laboratories

      9. 6.1.9 Instrumentation Laboratory

      10. 6.1.10 Beckman Coulter Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Coagulation Analyzers Market market is studied from 2018 - 2026.

The Coagulation Analyzers Market is growing at a CAGR of 8.85% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

F. Hoffmann-La Roche Ltd, Siemens Healthcare, Thermo Fisher Scientific, Beckman Coulter, Instrumentation Laboratory are the major companies operating in Coagulation Analyzers Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!